Physicians Explore Link Between Vitamin D Deficiency and Hypertension
November 25, 2009 By Chris DeFrancesco
Drs. William White and Pooja Luthra are studying the relationship between vitamin D deficiency and hypertension. Photo by Lanny Nagler
(PhysOrg.com) -- Drs. William White and Pooja Luthra at the University of Connecticut Health Center are investigating a possible link between vitamin D deficiency and high blood pressure.
Vitamin D is known to be important to bone health, but what about heart health?
UConn Health Center physician-scientists are looking into a possible link between vitamin D deficiency and high blood pressure.
“Often patients don’t realize they have a vitamin D deficiency, or are unaware of its relationship with health problems other than bone disorders,” says Dr. William B. White, professor of medicine and a hypertension expert in the Pat and Jim Calhoun Cardiology Center. White served as the study’s principal investigator.
White and Dr. Pooja Luthra, assistant professor of medicine and an endocrinologist in the New England Musculoskeletal Institute, are recruiting patients with a diagnosis of treated or untreated high blood pressure and a vitamin D level in the insufficient range of 12 to 29. They also must not be taking regular doses of vitamin D.
“Epidemiologic studies have shown an association between measured vitamin D deficiency and increased risk for incident hypertension that is independent of age, body mass index, physical activity, race, and menopausal status,” Luthra says. “There is a need for clinical research studies that evaluate the effects of antihypertensive drugs in hypertensive patients with documented vitamin D insufficiency.”
“One of the possible mechanisms of elevated blood pressure in patients with vitamin D deficiency is the activation of renin, an enzyme produced in the kidney,” White says.
Research involving genomic mouse models found that those with vitamin D deficiency developed elevated production of renin and the protein angiotensin II, leading to hypertension.
In the 14-week, double-blind, randomized trial, participants will first receive either vitamin D replacement or the renin inhibitor aliskiren, then both medications in combination. White and Luthra will assess the corresponding changes in blood pressure both in the office setting and over a 24-hour period using ambulatory blood pressure monitoring, calcium and vitamin D concentrations, and biochemical parameters involving the renin-angiotensin system.
“We have reason to believe there’s a connection here, and this research will increase our knowledge regarding vitamin D as a cardiovascular risk factor,” White says. “We will try to establish the effects of vitamin D replacement and the impact of direct inhibition of renin in patients with vitamin D deficiency on blood pressure. In the end, we hope that we can spread awareness about the association so that if patients with hypertension ask their doctors, ‘What if I have vitamin D deficiency?’ then their doctors will be prepared to make informed decisions about what to do about this problem.”
The UConn Health Center study is supported by an independent $480,000 investigator-initiated grant from Novartis Pharmaceuticals, Inc., in East Hanover, N.J., over the next three years.
-
Low vitamin D levels may be common in otherwise healthy children
Jul 09, 2007 |
not rated yet |
0
-
Vitamin D tied to muscle power in adolescent girls
Feb 03, 2009 |
not rated yet |
0
-
'Let the sunshine in' to protect your heart this winter
Nov 17, 2008 |
not rated yet |
0
-
Vitamin D deficiency in younger women increases risk of high blood pressure
Sep 24, 2009 |
not rated yet |
0
-
Seasonal variation in blood pressure
Jan 16, 2009 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
New understanding of DNA repair could eventually lead to cancer therapy
A research group in the Faculty of Medicine & Dentistry at the University of Alberta is hoping its latest discovery could one day be used to develop new therapies that target certain types of cancers.
25 minutes ago |
5 / 5 (1) |
0
|
Antidepressants and pregnancy: Women must consider the impact of drugs on baby, and of depression on baby, themselves
Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine. But what about antidepressants?
Medicine & Health / Medications
1 hour ago |
not rated yet |
0
Both maternal and paternal age linked to autism
Older maternal and paternal age are jointly associated with having a child with autism, according to a recently published study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Medicine & Health / Psychology & Psychiatry
34 minutes ago |
not rated yet |
0
|
Night, weekend delivery OK for babies with birth defects
Weekday delivery is no better than night or weekend delivery for infants with birth defects, according to a new study presented today at The Pregnancy Meeting, the Society for Maternal-Fetal Medicine's annual conference. ...
23 minutes ago |
not rated yet |
0
|
From virginity to Viagra
Americans will spend more than $17 billion on Valentine's Day, but far less on programs like sex education for adolescents. The editors of the new book, Sex for Life, From Virginity to Viagra, How Sexuality Changes Throughout ...
26 minutes ago |
not rated yet |
0
Zuckerberg's focus drives Facebook's ascent
When Mark Zuckerberg showed up to rent Judy Fusco's Los Altos, Calif., house in the fall of 2004, soon after he'd arrived in Silicon Valley, the landlord was immediately struck by his confidence.
Sonic Cradle lands spot in TED exhibition
A Simon Fraser University graduate student project that melds music, meditation and modern technology has landed a rare spot as an exhibit at TEDActive 2012 in Palm Springs, California this month.
The power of estrogen -- male snakes attract other males
A new study has shown that boosting the estrogen levels of male garter snakes causes them to secrete the same pheromones that females use to attract suitors, and turned the males into just about the sexiest ...
Curry spice component may help slow prostate tumor growth
Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study from researchers ...
Fool's gold may prove an unlikely alternative to overexploited catalytic materials
Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...
Netflix light on flicks as viewers soak up TV shows
Like most fresh faces that arrive in Hollywood, Netflix wanted to be a movie star. But now it's learning what many in Tinseltown have known for decades: Movies are sexy, but the real money is in television.
Nov 26, 2009
Rank: not rated yet
The level at which human breast milk naturally flows replete with vitamin D is around 60ng/ml.
The level associated with least cancer, diabetes, heart disease and other chronic illness is found is around 55ng/ml.
Ideal 25(OH)D levels are therefore very different from those suggested by those with a vested interest in promoting drug sales.
To correct vitamim D insufficiency generally takes 8~12 weeks daily consumption of 5000iu/D3.
Only above 50ng/ml is there a reserve of D3.
Only if all trial participants achieve effective 25(OH)D levels will anything new be learnt.
I suspect all this trial will confirm is that, too little, of the wrong kind of vitamin D, for far too short a period, does nothing very much at all.
Dec 10, 2009
Rank: not rated yet